StoneX Group’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$67.9K Buy
+14,199
New +$70.4K ﹤0.01% 1202
2025
Q1
Sell
-12,627
Closed -$50.3K 935
2024
Q4
$50.3K Buy
12,627
+1,000
+9% +$4.48K ﹤0.01% 784
2024
Q3
$68.9K Buy
11,627
+209
+2% +$1.03K 0.01% 601
2024
Q2
$50.9K Buy
11,418
+1,100
+11% +$5.27K ﹤0.01% 590
2024
Q1
$48.5K Sell
10,318
-8,696
-46% -$33.3K ﹤0.01% 564
2023
Q4
$95K Buy
19,014
+399
+2% +$1.95K 0.01% 542
2023
Q3
$104K Buy
18,615
+884
+5% +$7.08K 0.01% 560
2023
Q2
$169K Sell
17,731
-754
-4% -$6.38K 0.02% 536
2023
Q1
$157K Buy
18,485
+5,021
+37% +$55.4K 0.02% 550
2022
Q4
$154K Buy
13,464
+2,869
+27% +$33.4K 0.02% 502
2022
Q3
$128K Buy
+10,595
New +$160K 0.02% 467

Other funds holding MPT

StoneX Group's MPT Position: Q2 2026 in Review

StoneX Group opened a new position in Medical Properties Trust (MPT) in Q2 2026: 14,199 shares worth $67.9K. The stake represents ﹤0.01% of the portfolio and ranks #1202 among its holdings. This is a return to the name: StoneX Group previously reported a position in MPT as recently as Q4 2024.

StoneX Group first reported a position in MPT in Q3 2022 and has held it in 11 quarters since. The position peaked at $169K in Q2 2023. 489 funds tracked by Wall St. Rank hold MPT as of Q2 2026.

  • StoneX Group held 14,199 shares of Medical Properties Trust worth $67.9K as of Q2 2026.
  • Medical Properties Trust was a new StoneX Group position in Q2 2026.
  • Medical Properties Trust made up ﹤0.01% of StoneX Group's portfolio in Q2 2026, its #1202 holding.
  • StoneX Group first reported a position in Medical Properties Trust in Q3 2022 and has held it in 11 quarters since.
  • StoneX Group's Medical Properties Trust position peaked at $169K in Q2 2023.
  • 489 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2026.

Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.